Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study
Launched by THE AFFILIATED HOSPITAL OF GUIZHOU MEDICAL UNIVERSITY · May 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called post-ICU syndrome, which can happen to patients after they leave the Intensive Care Unit (ICU). Researchers want to see how this syndrome develops over time—specifically, they will check in with patients at 7 days, 1 month, 3 months, and 6 months after leaving the ICU. They will use advanced computer models to identify different patterns of how this syndrome affects people and to create an early warning system that can help spot these changes quickly.
To participate in this study, individuals must be at least 18 years old, have stayed in the ICU for at least 24 hours, and be able to communicate clearly when leaving the ICU. However, people who had a serious illness before this ICU stay or who have significant hearing or speech issues will not be eligible. Participants can expect to be involved in regular follow-ups where they will answer questions about their health and well-being as the researchers gather important information to improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria patients :
- • Length of stay in ICU ≥24h;
- • Age ≥18 years old;
- • Conscious when leaving ICU, communicating with investigators without barriers;
- • Informed consent. Family members:
- • One family member ≥18 years of age was selected for each patient;
- • Assume the main role of caring for patients and medical decision-making;
- • No history of mental illness or other serious organic diseases;
- • Informed consent and voluntary participation in this study.
- Exclusion Criteria patients :
- • Have been in ICU for more than 24h within 3 months before this admission;
- • Transferred to another ICU;
- • Cognitive impairment existed before ICU admission (BDRS \> 4 points);
- • Severe hearing impairment, dysarthria, etc., which cannot be followed up;
- • Unable to complete the questionnaire survey due to serious illness.
- Family members:
- • Family members refuse to participate in the study due to their own reasons;
- • Severe hearing and language impairment, unable to cooperate with researchers.
About The Affiliated Hospital Of Guizhou Medical University
The Affiliated Hospital of Guizhou Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, the hospital fosters collaborations with academic and industry partners to explore novel therapies and interventions. Its strategic focus on patient-centered research underscores its mission to enhance the quality of care and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guiyang, Guizhou, China
Patients applied
Trial Officials
Li Yao
Study Chair
Affiliated Hospital of Guizhou Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported